Alleviant ALV1 System
DeviceCreation of interatrial shunt
NCT Number: NCT06812533
Prospective, multicenter, randomized, sham-controlled, double blind (patient and observer), study designed to evaluate the safety and efficacy of a percutaneously created interatrial shunt using the Alleviant ALV1 System in patients with HFrEF.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Monash Health Victorian Heart Hospital, Clayton, Victoria, Australia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Creation of interatrial shunt
Cardiac imaging
Time frame: 12-Month
The primary endpoint is a composite of all-cause mortality or cardiac transplantation or permanent left ventricular assist device (LVAD) and heart failure events.
Alleviant Medical, Inc.
Industry
Safety and Efficacy of the Alleviant No-Implant Interatrial Shunt in Patients With Heart Failure and Reduced Ejection Fraction
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06280820
Cardiovascular Diseases, Heart Diseases
Falls Church, Virginia, United States
View Trial DetailsNCT07730268
Cardiovascular Diseases, Disease
Long Beach, California, United States
View Trial DetailsNCT05791227
Cardiovascular Diseases, Heart Diseases
Los Angeles, California, United States
View Trial DetailsNCT05086978
Cardiovascular Diseases, Heart Diseases
Cleveland, Ohio, United States
View Trial Details